Metagenomi, Inc. (MGX)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Metagenomi Inc Is Being Looked Into For Securities Fraud And The Schall Law Firm Encourages Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors who Lost Money on Metagenomi, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - MGX
NEW YORK, NY / ACCESSWIRE / August 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Investors Can Join The Schall Law Firm In An Inquiry Into Whether Metagenomi Inc. Committed Securities Law Infractions
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Metagenomi Inc Is Being Looked Into For Securities Fraud And Shareholders Are Urged To Participate With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc. - MGX
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or the "Company"). [email protected] The investigation concerns whether Metagenomi and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Shareholder Rights Advocates at Levi & Korsinsky Investigate Metagenomi, Inc. (MGX) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Metagenomi Inc. For Possible Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Metagenomi, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - MGX
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Metagenomi Inc. Is Being Looked Into For Securities Fraud And The Schall Law Firm Wants Shareholders To Offer Assistance
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Metagenomi, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – MGX
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Metagenomi Being Investigated on Behalf of Metagenomi, Inc. Investors; Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
